CanSORT News
The latest from CanSORT
Research News
3 Questions on...Improving Cascade Genetic Testing
About 5%–10% of cancers are hereditary. For these cases, cascade genetic testing offers an opportunity to identify family members who may carry a clinically significant pathogenic variant.
Research News
Steven Katz on How Patients Do and Do Not Share Genetic Test Results
Patient engagement with clinicians and relatives about cascade genetic testing varies by genetic risk in families with hereditary cancer susceptibility, researchers reported in JCO Oncology Practice.
Health Lab
An online intervention can help cancer patients share genetic testing results with family
Katz and colleagues developed a web-based intervention to educate people with cancer about the impact genetic variants can have on their family.
More Featured News
The push to expand testing for cancer predisposition
Dr. Kurian participated in an interview with NPR recently and discussed genetic risk for cancer and under testing.
August 2, 2023
Testing your genes for cancer risk is way cheaper now – and it could save your life
Dr Kurian discussed her recent work highlighting under testing in an NPR article.
August 2, 2023
Germline Genetic Testing After Cancer Diagnosis
Dr. Allison Kurian’s and Dr. Steven Katz’s recent paper published on June 5th, 2023 and featured in JAMA, describes the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019. Her research has been featured in Stanford Medicine and USA Today.
June 21, 2023
